Clinically, the active fragment GSDMD-N localizes primarily to CD68+ macrophages, and its renal level positively correlates with fibrosis severity across diverse CKD etiologies, reinforcing its pathogenic relevance. The gene discussed is CD68; the disease is chronic kidney disease.